Gujarat State Fertilizers & Chemicals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 7:35 pm

Quick Insight

Gujarat State Fertilizers & Chemicals Ltd, with a share price of ₹200 and a market cap of ₹7,971 Cr., exhibits a P/E ratio of 13.5, ROE of 4.75%, and ROCE of 6.16%. The company's OPM stands at 4%, with a net profit of ₹591 Cr. Notably, promoters hold a significant stake at 37.84%, while FIIs and DIIs have 11.64% and 7.34% ownership, respectively. The company's strong ICR of 93.81x and low P/BV of 0.58x indicate potential undervaluation. However, the relatively low ROE and ROCE suggest room for improvement in efficiency and profitability to maximize shareholder value.

Competitors of Gujarat State Fertilizers & Chemicals Ltd

All Competitor Stocks of Gujarat State Fertilizers & Chemicals Ltd

Quarterly Result

Last Updated: May 31, 2025, 5:47 am

Below is a detailed analysis of the quarterly data for Gujarat State Fertilizers & Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 1,922.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,814.00 Cr. (Dec 2024) to 1,922.00 Cr., marking a decrease of 892.00 Cr..
• For Expenses, as of Mar 2025, the value is 1,842.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2,656.00 Cr. (Dec 2024) to 1,842.00 Cr., marking a decrease of 814.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 80.00 Cr.. The value appears to be declining and may need further review. It has decreased from 158.00 Cr. (Dec 2024) to 80.00 Cr., marking a decrease of 78.00 Cr..
• For OPM %, as of Mar 2025, the value is 4.00%. The value appears to be declining and may need further review. It has decreased from 6.00% (Dec 2024) to 4.00%, marking a decrease of 2.00%.
• For Other Income, as of Mar 2025, the value is 61.00 Cr.. The value appears strong and on an upward trend. It has increased from 60.00 Cr. (Dec 2024) to 61.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Mar 2025, the value is 4.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.00 Cr. (Dec 2024) to 4.00 Cr., marking an increase of 2.00 Cr..
• For Depreciation, as of Mar 2025, the value is 48.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 49.00 Cr. (Dec 2024) to 48.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 89.00 Cr.. The value appears to be declining and may need further review. It has decreased from 168.00 Cr. (Dec 2024) to 89.00 Cr., marking a decrease of 79.00 Cr..
• For Tax %, as of Mar 2025, the value is 19.00%. The value appears to be improving (decreasing) as expected. It has decreased from 20.00% (Dec 2024) to 19.00%, marking a decrease of 1.00%.
• For Net Profit, as of Mar 2025, the value is 72.00 Cr.. The value appears to be declining and may need further review. It has decreased from 134.00 Cr. (Dec 2024) to 72.00 Cr., marking a decrease of 62.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 1.80. The value appears to be declining and may need further review. It has decreased from 3.36 (Dec 2024) to 1.80, marking a decrease of 1.56.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 1:03 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:09 pm

Below is a detailed analysis of the balance sheet data for Gujarat State Fertilizers & Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 80.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 80.00 Cr..
• For Reserves, as of Mar 2025, the value is 12,059.00 Cr.. The value appears to be declining and may need further review. It has decreased from 12,647.00 Cr. (Mar 2024) to 12,059.00 Cr., marking a decrease of 588.00 Cr..
• For Borrowings, as of Mar 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 5.00 Cr. (Mar 2024) to 2.00 Cr., marking a decrease of 3.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 2,229.00 Cr.. The value appears to be improving (decreasing). It has decreased from 2,319.00 Cr. (Mar 2024) to 2,229.00 Cr., marking a decrease of 90.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 14,369.00 Cr.. The value appears to be improving (decreasing). It has decreased from 15,051.00 Cr. (Mar 2024) to 14,369.00 Cr., marking a decrease of 682.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 2,504.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,549.00 Cr. (Mar 2024) to 2,504.00 Cr., marking a decrease of 45.00 Cr..
• For CWIP, as of Mar 2025, the value is 690.00 Cr.. The value appears strong and on an upward trend. It has increased from 236.00 Cr. (Mar 2024) to 690.00 Cr., marking an increase of 454.00 Cr..
• For Investments, as of Mar 2025, the value is 5,055.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6,015.00 Cr. (Mar 2024) to 5,055.00 Cr., marking a decrease of 960.00 Cr..
• For Other Assets, as of Mar 2025, the value is 6,119.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6,251.00 Cr. (Mar 2024) to 6,119.00 Cr., marking a decrease of 132.00 Cr..
• For Total Assets, as of Mar 2025, the value is 14,369.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15,051.00 Cr. (Mar 2024) to 14,369.00 Cr., marking a decrease of 682.00 Cr..

Notably, the Reserves (12,059.00 Cr.) exceed the Borrowings (2.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Gujarat State Fertilizers & Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 14.83. This value is within the healthy range. It has increased from 14.16 (Mar 24) to 14.83, marking an increase of 0.67.
• For Diluted EPS (Rs.), as of Mar 25, the value is 14.83. This value is within the healthy range. It has increased from 14.16 (Mar 24) to 14.83, marking an increase of 0.67.
• For Cash EPS (Rs.), as of Mar 25, the value is 19.36. This value is within the healthy range. It has increased from 18.54 (Mar 24) to 19.36, marking an increase of 0.82.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 304.60. It has decreased from 319.42 (Mar 24) to 304.60, marking a decrease of 14.82.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 304.60. It has decreased from 319.42 (Mar 24) to 304.60, marking a decrease of 14.82.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 239.25. It has increased from 229.74 (Mar 24) to 239.25, marking an increase of 9.51.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 23.75. This value is within the healthy range. It has increased from 22.34 (Mar 24) to 23.75, marking an increase of 1.41.
• For PBIT / Share (Rs.), as of Mar 25, the value is 18.94. This value is within the healthy range. It has increased from 17.73 (Mar 24) to 18.94, marking an increase of 1.21.
• For PBT / Share (Rs.), as of Mar 25, the value is 18.68. This value is within the healthy range. It has increased from 17.45 (Mar 24) to 18.68, marking an increase of 1.23.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 14.54. This value is within the healthy range. It has increased from 13.94 (Mar 24) to 14.54, marking an increase of 0.60.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 14.83. This value is within the healthy range. It has increased from 14.15 (Mar 24) to 14.83, marking an increase of 0.68.
• For PBDIT Margin (%), as of Mar 25, the value is 9.92. This value is below the healthy minimum of 10. It has increased from 9.72 (Mar 24) to 9.92, marking an increase of 0.20.
• For PBIT Margin (%), as of Mar 25, the value is 7.91. This value is below the healthy minimum of 10. It has increased from 7.71 (Mar 24) to 7.91, marking an increase of 0.20.
• For PBT Margin (%), as of Mar 25, the value is 7.80. This value is below the healthy minimum of 10. It has increased from 7.59 (Mar 24) to 7.80, marking an increase of 0.21.
• For Net Profit Margin (%), as of Mar 25, the value is 6.07. This value is within the healthy range. It has increased from 6.06 (Mar 24) to 6.07, marking an increase of 0.01.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.19. This value is below the healthy minimum of 8. It has increased from 6.16 (Mar 24) to 6.19, marking an increase of 0.03.
• For Return on Networth / Equity (%), as of Mar 25, the value is 4.86. This value is below the healthy minimum of 15. It has increased from 4.43 (Mar 24) to 4.86, marking an increase of 0.43.
• For Return on Capital Employeed (%), as of Mar 25, the value is 5.77. This value is below the healthy minimum of 10. It has increased from 5.13 (Mar 24) to 5.77, marking an increase of 0.64.
• For Return On Assets (%), as of Mar 25, the value is 4.11. This value is below the healthy minimum of 5. It has increased from 3.74 (Mar 24) to 4.11, marking an increase of 0.37.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.64. It has increased from 0.63 (Mar 24) to 0.64, marking an increase of 0.01.
• For Current Ratio (X), as of Mar 25, the value is 4.34. This value exceeds the healthy maximum of 3. It has decreased from 4.37 (Mar 24) to 4.34, marking a decrease of 0.03.
• For Quick Ratio (X), as of Mar 25, the value is 3.20. This value exceeds the healthy maximum of 2. It has decreased from 3.37 (Mar 24) to 3.20, marking a decrease of 0.17.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.59. This value is below the healthy minimum of 4. It has decreased from 3.62 (Mar 24) to 3.59, marking a decrease of 0.03.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 70.64 (Mar 24) to 0.00, marking a decrease of 70.64.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 53.30 (Mar 24) to 0.00, marking a decrease of 53.30.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 29.36 (Mar 24) to 0.00, marking a decrease of 29.36.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 46.70 (Mar 24) to 0.00, marking a decrease of 46.70.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 93.81. This value is within the healthy range. It has increased from 79.50 (Mar 24) to 93.81, marking an increase of 14.31.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 58.42. This value is within the healthy range. It has increased from 50.61 (Mar 24) to 58.42, marking an increase of 7.81.
• For Enterprise Value (Cr.), as of Mar 25, the value is 5,168.98. It has decreased from 5,497.06 (Mar 24) to 5,168.98, marking a decrease of 328.08.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.54. This value is below the healthy minimum of 1. It has decreased from 0.60 (Mar 24) to 0.54, marking a decrease of 0.06.
• For EV / EBITDA (X), as of Mar 25, the value is 5.46. This value is within the healthy range. It has decreased from 6.18 (Mar 24) to 5.46, marking a decrease of 0.72.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 0.85 (Mar 24) to 0.74, marking a decrease of 0.11.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 29.35 (Mar 24) to 0.00, marking a decrease of 29.35.
• For Price / BV (X), as of Mar 25, the value is 0.58. This value is below the healthy minimum of 1. It has decreased from 0.61 (Mar 24) to 0.58, marking a decrease of 0.03.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 0.85 (Mar 24) to 0.74, marking a decrease of 0.11.
• For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.07 (Mar 24) to 0.08, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness